Positive CD34 expression is adversely associated with outcome in AML with NPM1mut/FLT3‐ITD(+) where initial ID‐Ara‐C induction and allo‐SCT consolidation can benefit efficacy. The gene discussed is CD34; the disease is acute myeloid leukemia.